Figure 2

Figure 2. Summary of FAMMM diagnostic criteria, CDKN2A mutation prevalence in FAMMM and penetrance of melanoma and pancreatic cancer in CDKN2A mutation carrier and non carrier FAMMM patients. Note that cancer risks reported for FAMMM vary widely (4, 6, 11, 17, 25, 26, 39).

From: Familial Atypical Multiple Mole Melanoma Syndrome

Cover of Cancer Syndromes
Cancer Syndromes [Internet].
Riegert-Johnson DL, Boardman LA, Hefferon T, et al., editors.
Copyright © 2009-, Douglas L Riegert-Johnson.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.